CABA — CABALETTA BIO INC

Ownership history in Caption Management, LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in CABALETTA BIO INC (CABA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.11% (2024 Q1)
Avg. % of fund
0.03%
First filed
2021 Q4
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 250,000 +246,111 +6328.4% 0.00% $585K $2.34
2024 Q2 REDUCED 3,889 -421,111 -99.1% 0.00% $29K $7.48
2024 Q1 ADDED 425,000 +265,000 +165.6% 0.11% $7.3M $17.06
2024 Q1 ADDED 160,000 +121,700 +317.8% 0.04% $2.7M $17.06
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CABA price (monthly, adj. close)

Other funds also holding CABA

As of 2025 Q4 — sorted by position size

SUPERSTRING CAPITAL MANAGEMENT LP 2.64% Bain Capital Life Sciences Investors, LLC 3Y 7Y 1.62% Cormorant Asset Management, LP 3Y 7Y 0.45% Stonepine Capital Management, LLC 3Y 7Y 0.27% Opaleye Management Inc. 3Y 7Y 0.26% Almitas Capital LLC 3Y 7Y 0.19% Ikarian Capital, LLC 3Y 0.15% Burkehill Global Management, LP 0.1% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.06% 683 Capital Management, LLC 3Y 7Y 0.04%
← Back to Caption Management, LLC Holdings